Skip to main content
. 2019 Feb 21;9:2516. doi: 10.1038/s41598-019-38676-7

Figure 4.

Figure 4

Afatinib attenuated OGD-induced increases in COX-II, iNOS and NO levels. (A) CTX-TNA2 cells were exposed to oxygen-glucose deprivation (OGD) for various durations (3, 6, 12 h). Western blot assay was employed to measure COX-II, iNOS and β-Actin. Each lane contained 40 μg protein for all experiments. Graphs show statistical results of COX-II and iNOS from relative optical density of bands on the blots. Values are the mean ± S.E.M. (n = 3/group).*P < 0.05 in the OGD group compared with the control by t-test. (B) CTX-TNA2 cells were exposed to 12-h OGD. Afatinib (1, 10 nM) was included in the culture medium concomitantly with OGD exposure. Graphs show statistical results of COX-II and iNOS levels from relative optical density of bands on the blots. Values are the mean ± S.E.M. (n = 3/group). (C) CTX-TNA2 cells and (D) Primary cultured astrocytes were exposed to 24 h-OGD or 12 h-OGD, respectively. Afatinib (1, 10 nM) was included in the culture medium concomitantly with OGD exposure. The levels of NO were measured using Griess reaction. Values are the mean ± S.E.M. (n = 3/group). *P < 0.05 in the OGD group compared with the control, #P < 0.05 in OGD plus afatinib compared with OGD alone by Kruskal-Wallis test and followed by Mann-Whitney U test as post-hoc method.